Featured

SignaCase: A Case Review: Long-term stable disease on immunotherapy



Published
Signatera is a tumor-informed blood test that can help monitor response to immunotherapy and clarify indeterminate imaging results, giving patients the answers they need to plan their treatment and the peace of mind to live the life they knew before diagnosis.
Category
Health
Be the first to comment